Sinclair Research’s Response To COVID-19 Pandemic
OUR SERVICES
Pharmaceutical Development
Animal Health
Medical Device
Bio Resources
Resources
News
White Papers
Events
Scientific Posters
Sinclair Research’s Response to the COVID-19 Pandemic
I want to take the opportunity to speak to you about what Sinclair Research is doing to address the novel Coronavirus, COVID-19. First, and most importantly, I want to stress how seriously we take our role in supporting your important research. Sinclair Research takes...
Sinclair Research Announces Toxicology Laboratory Expansion
Auxvasse, Mo. — Sinclair Research, a leading provider of nonclinical contract research services, will officially open its 20,000-square-foot laboratory expansion later this spring. The additional capacity will support GLP nonclinical toxicology research studies to...
Ian Vanterpool named Vice President of Operations at Sinclair Research
Auxvasse, Mo. -- Sinclair Research, one of the leading providers of nonclinical research services, has named Ian Vanterpool as Vice President of Operations. In this newly created role, Vanterpool will have overall responsibility for driving operational excellence and...
Sinclair Research Announces Expansion into Safety Pharmacology Services with CorDynamics Partnership
Auxvasse, Mo. -- Sinclair Research, a leading provider of nonclinical contract research services, today announced an agreement to acquire the assets of the GLP safety pharmacology business unit of CorDynamics, a premier provider of cardiovascular toxicology and safety...
Sinclair Research and Turner Scientific Announce Exclusive Partnership to Offer GLP Ototoxicity Testing Services
COLUMBIA, Mo.--(BUSINESS WIRE)--Sinclair Research, a leading provider of nonclinical services, and Turner Scientific, an industry leader specializing in nonclinical hearing research, have formed an exclusive partnership to offer GLP auditory testing to evaluate...
Why Sinclair Research?
